AV-GBM-1 / AiVita Biomedical 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AV-GBM-1 / AiVita Biomedical
NCT05100641: AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM

Not yet recruiting
3
672
NA
AV-GBM-1, Autologous monocytes
Aivita Biomedical, Inc.
Primary Glioblastoma
03/28
03/29
NCT03400917: Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma

Active, not recruiting
2
55
US
AV-GBM-1
Aivita Biomedical, Inc.
Newly Diagnosed Glioblastoma
12/21
02/23

Download Options